A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer

The most frequent malignancy of the pancreas is the pancreatic ductal adenocarcinoma (PDAC). Despite many efforts PDAC has still a dismal prognosis. Biomarkers for early disease stage diagnosis as a prerequisite for a potentially curative treatment are still missing. Novel blood-based markers may he...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Andreas W., Schwerdel, Daniel, Reinacher-Schick, Anke, Uhl, Waldemar, Algül, Hana, Friess, Helmut, Janssen, Klaus-Peter, König, Alexander, Ghadimi, Michael, Gallmeier, Eike, Bartsch, Detlef K., Geissler, Michael, Staib, Ludger, Tannapfel, Andrea, Kleger, Alexander, Beutel, Alica, Schulte, Lucas-Alexander, Kornmann, Marko, Ettrich, Thomas J., Seufferlein, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401492/
https://www.ncbi.nlm.nih.gov/pubmed/30867830
http://dx.doi.org/10.7150/thno.29247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401492/
https://www.ncbi.nlm.nih.gov/pubmed/30867830
http://dx.doi.org/10.7150/thno.29247

Ejemplares similares